Vascular endothelial growth factor (VEGF) in serum and exhaled breath condensate (EBC) of subjects with non-small cell lung cancer (NSCLC) Source: Eur Respir J 2007; 30: Suppl. 51, 205s Year: 2007
Detection of p53 mutation in exhaled breath condensate from patients with nonsmall cell lung cancer Source: Eur Respir J 2002; 20: Suppl. 38, 14s Year: 2002
Vascular endothelial growth factor (VEGF) in serum and exhaled breath condensate (EBC) as a potential biomarker for early detection of non-small cell lung cancer (NSCLC) Source: Annual Congress 2008 - Biology in thoracic tumours Year: 2008
Protein markers in the exhaled breath condensate of lung carcinoma patients Source: Annual Congress 2012 - Exhaled biomarkers in airway diseases Year: 2012
HPV in exhaled breath condensate of lung cancer patients Source: Annual Congress 2011 - Role of the biomarkers in airway diseases Year: 2011
The clinical significance of growth factors measurement in exhaled breath condensates (EBC) among patients with interstitial lung diseases Source: Annual Congress 2010 - Biomarkers in diffuse parenchymal lung disease Year: 2010
Pretreatment levels of TNF-α in serum and exhaled breath condensate in patients with lung cancer Source: Annual Congress 2007 - Biology of thoracic malignancies Year: 2007
Pretreatment levels of VEGF and 8-isoprostane in exhaled breath condensate (EBC) and serum of lung cancer patients Source: Annual Congress 2008 - Diagnostic aspects in thoracic oncology Year: 2008
Exhaled biomarkers in lung cancer Source: Eur Respir J 2009; 34: 261-275 Year: 2009
Inflammatory cytokines in exhaled breath condensate (EBC) of exacerbated COPD patients Source: Annual Congress 2008 - Inflammatory biomarkers Year: 2008
Comparing exhaled molecular profiles of patients with non-small cell lung cancer (NSCLC) with those of patients with non-pulmonary malignancy Source: Annual Congress 2010 - Exhaled biomarkers: smells like disease Year: 2010
Cytokine pattern in the exhaled breath of patients with planocellular lung carcinomas Source: Annual Congress 2008 - Airway cell biology and immunology Year: 2008
Relationships between the concentrations of NO, IL1β, TNF-α, IL-6 in exhaled breath condensate (EBC) and lung function in patient with COPD Source: Eur Respir J 2005; 26: Suppl. 49, 61s Year: 2005
The relationship between CT assessed lung damage, and inflammatory markers in exhaled breath condensate of cystic fibrosis patients Source: Annual Congress 2007 - Cystic fibrosis lung disease: what do we measure? What do we know? Year: 2007
Inflammatory markers in the exhaled breath condensate from patients with pulmonary sarcoidosis: comparison with BALF Source: Eur Respir J 2006; 28: Suppl. 50, 353s Year: 2006
Correlation between lung function and exhaled breath condensate biomarkers of inflammation in pulmonary diseases Source: Annual Congress 2009 - Lung function in adults and children Year: 2009
Tumour infiltrating lymphocytes and tumour associated macrophages in chronic obstructive pulmonary disease (COPD) patients with non-small cell lung cancer (NSCLC) and in patients with NSCLC Source: Eur Respir J 2005; 26: Suppl. 49, 92s Year: 2005
Detection of angiogenesis, antiangiogenesis and hypoxia related molecules in plasma and exhaled breath condensate (EBC): evaluation of potential biomarkers Source: Annual Congress 2009 - Airway inflammation and host defence Year: 2009
Periostin in exhaled breath condensate as a biomarker of different severe asthma phenotypes. Source: International Congress 2017 – Systemic and airway biomarkers Year: 2017
Early detection of lung cancer in exhaled breath condensate using miRNA markers Source: International Congress 2015 – Developments in lung cancer diagnosis Year: 2015